Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-21-028467
Filing Date
2021-11-05
Accepted
2021-11-05 16:22:54
Documents
1
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 8029
  Complete submission text file 0001127602-21-028467.txt   9537
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 GALLOPING HILL RD KENILWORTH NJ 07033
Business Address
Litchfield Caroline (Reporting) CIK: 0001854928 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 211384863